Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Burger

Showing results (41-50 of 337) with videos related to

Pageof 34
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2004
The effect of nevirapine on the pharmacokinetics of indinavir/ritonavir 800/100 mg BIDDavid M Burger, Jan M Prins, Marchina E van der Ende, et al.
Annals of Hepatology|May 9, 2018
The Observed Effect of Gastric Bypass Surgery on Direct-acting Antiviral Treatment: a Case ReportElise J Smolders, Sophie B Willemse, Omar El-Sherif, et al.
AIDS (London, England)|April 20, 2004
Pharmacokinetics of indinavir/ritonavir (800/100 mg twice a day) combined with efavirenz in HIV-infected patientsRob E Aarnoutse, Kees Brinkman, Jorge Benetucci, et al.
International Journal of Pharmaceutics|May 28, 2013
Controlled release of morphine from a poloxamer 407 gelMark M P M Jansen, Jacques M Verzijl, David M Burger, et al.
Clinical Pharmacokinetics|August 27, 2005
Pharmacokinetics of antiretroviral therapy in HIV-1-infected childrenPieter L A Fraaij, Jeroen J A van Kampen, David M Burger, et al.
Therapeutic Drug Monitoring|December 6, 2013
Nevirapine concentrations in saliva measured by thin layer chromatography and self-reported adherence in patients on antiretroviral therapy at Kilimanjaro Christian Medical Centre, TanzaniaLutengano George, Eva P Muro, Arnold Ndaro, et al.
AIDS (London, England)|May 12, 2016
Dolutegravir is not removed during hemodialysisPauline D J Bollen, Bart J A Rijnders, Marga J A Teulen, et al.
Clinical Pharmacology and Therapeutics|July 18, 2019
Concomitant Intake of Coca-Cola to Manage the Drug-Drug Interaction Between Velpatasvir and Omeprazole Studied in Healthy VolunteersMinou van Seyen, Angela Colbers, Evertine J Abbink, et al.
AIDS (London, England)|December 24, 2009
Pharmacokinetics of double-dose raltegravir in two patients with HIV infection and tuberculosisDavid M Burger, Cecile Magis-Escurra, Guido El van den Berk, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 28, 2020
A population pharmacokinetics analysis assessing the exposure of raltegravir once-daily 1200 mg in pregnant women living with HIVVera E Bukkems, Teun M Post, Angela P Colbers, et al.
Pageof 34

Showing results (41-50 of 337) with videos related to

Sort By:
Pageof 34
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2004
The effect of nevirapine on the pharmacokinetics of indinavir/ritonavir 800/100 mg BIDDavid M Burger, Jan M Prins, Marchina E van der Ende, et al.
Annals of Hepatology|May 9, 2018
The Observed Effect of Gastric Bypass Surgery on Direct-acting Antiviral Treatment: a Case ReportElise J Smolders, Sophie B Willemse, Omar El-Sherif, et al.
AIDS (London, England)|April 20, 2004
Pharmacokinetics of indinavir/ritonavir (800/100 mg twice a day) combined with efavirenz in HIV-infected patientsRob E Aarnoutse, Kees Brinkman, Jorge Benetucci, et al.
International Journal of Pharmaceutics|May 28, 2013
Controlled release of morphine from a poloxamer 407 gelMark M P M Jansen, Jacques M Verzijl, David M Burger, et al.
Clinical Pharmacokinetics|August 27, 2005
Pharmacokinetics of antiretroviral therapy in HIV-1-infected childrenPieter L A Fraaij, Jeroen J A van Kampen, David M Burger, et al.
Therapeutic Drug Monitoring|December 6, 2013
Nevirapine concentrations in saliva measured by thin layer chromatography and self-reported adherence in patients on antiretroviral therapy at Kilimanjaro Christian Medical Centre, TanzaniaLutengano George, Eva P Muro, Arnold Ndaro, et al.
AIDS (London, England)|May 12, 2016
Dolutegravir is not removed during hemodialysisPauline D J Bollen, Bart J A Rijnders, Marga J A Teulen, et al.
Clinical Pharmacology and Therapeutics|July 18, 2019
Concomitant Intake of Coca-Cola to Manage the Drug-Drug Interaction Between Velpatasvir and Omeprazole Studied in Healthy VolunteersMinou van Seyen, Angela Colbers, Evertine J Abbink, et al.
AIDS (London, England)|December 24, 2009
Pharmacokinetics of double-dose raltegravir in two patients with HIV infection and tuberculosisDavid M Burger, Cecile Magis-Escurra, Guido El van den Berk, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 28, 2020
A population pharmacokinetics analysis assessing the exposure of raltegravir once-daily 1200 mg in pregnant women living with HIVVera E Bukkems, Teun M Post, Angela P Colbers, et al.
Pageof 34